Protheragen-ING

Protheragen-ING logo

Protheragen-ING is engaged in the introduction of various chemical products to the global market, including active pharmaceutical ingredients (APIs), pharmaceutical excipients, veterinary chemicals, membrane materials, packaging materials. We are also a solution provider for chemistry-related analysis services.

Company Website

Product Listing

Hydroxychloroquine inquiry  | Purity Not Available

Protheragen-ING

An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions. It has a role as an antimalarial, an antirheumatic drug, a dermatologic drug and an anticoronaviral agent.

More Information Supplier Page

Hydroxychloroquine Sulfate inquiry  | Purity Not Available

Protheragen-ING

A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase.

More Information Supplier Page

Hydroxyethyl Starch 130/0.4 inquiry  | Purity Not Available

Protheragen-ING

Hydroxyethyl starch is a prominent pharmaceutical compound, standing resolute in its pivotal role as a plasma volume expander to aid in studying the distressing affliction of hypovolemia.

More Information Supplier Page

Hydroxypinacolone Retinoate 10% inquiry  | Purity Not Available

Protheragen-ING

Hydroxypinacolone Retinoate (HPR) is a revolutionary new retinoid. Compared with other vitamin A products, it can directly work through the excitatory receptor without metabolic transformation (generally retinoids need to be transformed in the skin in two steps). It is less irritating, highly potent, more stable, and less likely to be oxidized. It is a safe […]

More Information Supplier Page

Hyperoside inquiry  | Purity Not Available

Protheragen-ING

Quercetin 3-O-beta-D-galactopyranoside is a quercetin O-glycoside that is quercetin with a beta-D-galactosyl residue attached at position 3. Isolated from Artemisia capillaris, it exhibits hepatoprotective activity. It has a role as a hepatoprotective agent and a plant metabolite. It is a tetrahydroxyflavone, a monosaccharide derivative, a beta-D-galactoside and a quercetin O-glycoside.

More Information Supplier Page

Ibandronate Sodium inquiry  | Purity Not Available

Protheragen-ING

Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.

More Information Supplier Page

Ibrutinib deacryloylpiperidine inquiry  | Purity Not Available

Protheragen-ING

Ibrutinib Impurity 8 is a useful synthetic intermediate in the synthesis of Ibrutinib, a highly selective Bruton’s tyrosine kinase (BTK) irreversible inhibitor.

More Information Supplier Page

Ibrutinib Intermediate 2 inquiry  | Purity Not Available

Protheragen-ING

Ibrutinib is a small molecule that acts as an irreversible potent inhibitor of Burton’s tyrosine kinase. It is designated as a targeted covalent drug and presented as a promising activity in B-cell malignancies in clinical trials.

More Information Supplier Page

iBu-dG Phosphoramidite inquiry  | Purity Not Available

Protheragen-ING

5′-O-DMT-N2-isobutyryl-2′-deoxyguanosine 3′-CE phosphoramidite is a pivotal compound employed in oligonucleotide research within the biomedical sector, emerging as an instrumental factor for nucleic acid modification, labeling and analysis.

More Information Supplier Page

Ibuprofen inquiry  | Purity Not Available

Protheragen-ING

Ibuprofen is an anti-inflammatory inhibitor targeting COX-1 and COX-2 with IC50 of 13 μM and 370 μM, respectively.

More Information Supplier Page

ICARITIN inquiry  | Purity Not Available

Protheragen-ING

Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).

More Information Supplier Page

Idarubicin inquiry  | Purity Not Available

Protheragen-ING

An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.

More Information Supplier Page

Idarubicin HCL Intermediates 2 inquiry  | Purity Not Available

Protheragen-ING

N-(Trifluoroacetyl)-1-desmethyl Daunorubicin is a derivative of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression.

More Information Supplier Page

Idelalisib inquiry  | Purity Not Available

Protheragen-ING

It has a role as an antineoplastic agent, an apoptosis inducer and an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor. It is a member of purines, an organofluorine compound, a member of quinazolines, an aromatic amine and a secondary amino compound.

More Information Supplier Page

Ifosfamide inquiry  | Purity Not Available

Protheragen-ING

Ifosfamide is the simplest member of the class of ifosfamides that is 1,3,2-oxazaphosphinan-2-amine 2-oxide substituted by 2-chloroethyl groups on both the nitrogen atoms respectively. It is a nitrogen mustard alkylating agent used in the treatment of advanced breast cancer. It has a role as an antineoplastic agent, an immunosuppressive agent, an alkylating agent, an environmental […]

More Information Supplier Page

Iguratimod inquiry  | Purity Not Available

Protheragen-ING

Iguratimod is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor.

More Information Supplier Page

Iguratimod inquiry  | Purity Not Available

Protheragen-ING

Iguratimod is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM.

More Information Supplier Page

Ilaprazole inquiry  | Purity Not Available

Protheragen-ING

Ilaprazole is a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity. A weak base, ilaprazole accumulates in the acidic environment of the secretory canaliculus of the gastric parietal cell where it is converted to an active sulfenamide form that binds to cysteine sulfhydryl groups on the luminal aspect of the proton pump […]

More Information Supplier Page

Iloprost inquiry  | Purity Not Available

Protheragen-ING

A synthetic analogue of prostacyclin, it is used as the trometamol salt (generally by intravenous infusion) for the treatment of peripheral vascular disease and pulmonary hypertension. It has a role as a platelet aggregation inhibitor and a vasodilator agent.

More Information Supplier Page

Imatinib inquiry  | Purity Not Available

Protheragen-ING

Used (as its mesylate salt) for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. It has a role as an apoptosis inducer, a tyrosine kinase inhibitor and an antineoplastic agent.

More Information Supplier Page

Imatinib Mesylate inquiry  | Purity Not Available

Protheragen-ING

Imatinib mesylate is a c-Abl, PDGFR, and c-kit inhibitor that halts chronic myelogenous leukemia related growth.

More Information Supplier Page

Imatinib Mesylate Tablets inquiry  | Purity Not Available

Protheragen-ING

A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

More Information Supplier Page

Imatinib Mesylate(α form) inquiry  | Purity Not Available

Protheragen-ING

A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

More Information Supplier Page

Imatinib Mesylate(β form) inquiry  | Purity Not Available

Protheragen-ING

A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

More Information Supplier Page

Imidacloprid inquiry  | Purity Not Available

Protheragen-ING

It is marketed as pest control, seed treatment, an insecticide spray, termite control, flea control, and a systemic insecticide.

More Information Supplier Page

imidapril hydrochloride inquiry  | Purity Not Available

Protheragen-ING

Imidapril Hydrochloride is the hydrochloride salt of Imidapril, an angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity.

More Information Supplier Page

Imidocarb inquiry  | Purity Not Available

Protheragen-ING

Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia and other parasites.

More Information Supplier Page

IMP.Na2 inquiry  | Purity Not Available

Protheragen-ING

It is used as a food additive and often found in instant noodles, potato chips, and a variety of other snacks. This salt is used as a flavor enhancer made from microbial fermentation growth media that are all-vegetable, usually consisting mainly of tapioca starch.

More Information Supplier Page

Imperatorin inquiry  | Purity Not Available

Protheragen-ING

Imperatorin is a member of the class of psoralens that is psoralen substituted by a prenyloxy group at position 8. Isolated from Angelica dahurica and Angelica koreana, it acts as a acetylcholinesterase inhibitor. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor and a metabolite.

More Information Supplier Page

Imrecoxib inquiry  | Purity Not Available

Protheragen-ING

Imrecoxib is a selective cyclooxygenase 2 (COX-2) inhibitor (IC50 = 18 nM) with anti-inflammatory effect. It also inhibits COX-1 activity with an IC50 value of 115 nM.

More Information Supplier Page

Inclisiran inquiry  | Purity Not Available

Protheragen-ING

Inclisiran is a double-stranded small interfering RNA(siRNA) molecule that inhibits PCSK-9 transcription and can be used in hyperlipidemia and cardiovascular disease.

More Information Supplier Page

Inclisiran inquiry  | Purity Not Available

Protheragen-ING

Inclisiran is a double-stranded small interfering RNA (siRNA) molecule that inhibits the transcription of PCSK-9. Inclisiran can be used for hyperlipidemia and cardiovascular disease (CVD) research.

More Information Supplier Page

Indacaterol Maleate inquiry  | Purity Not Available

Protheragen-ING

Used for treatment of chronic obstructive pulmonary disease. It has a role as a beta-adrenergic agonist and a bronchodilator agent.

More Information Supplier Page

Indigo inquiry  | 0.98%

Protheragen-ING

Indigo, which can be found in the leaves of Isatis indigotica Fortune, participates in isolating oxygenase genes. Indigo carmine angiography provides visual information on foot perfusion.

More Information Supplier Page

Indobufen inquiry  | Purity Not Available

Protheragen-ING

Antiplatelet aggregating agent for atherosclerotic ischemic cardiovascular lesions, ischemic cerebrovascular lesions and peripheral arterial lesions, disorders of lipid metabolism, venous thrombosis and diabetes mellitus. It is also used to prevent thrombosis during extracorporeal circulation surgery.

More Information Supplier Page